Show Summary Details
Page of

Embolic disease 

Embolic disease
Embolic disease

Raman Sivasankar

and Sarah Harries

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 13 July 2020

Women are 2–5 times more likely to develop a deep vein thrombosis or suffer a pulmonary embolism during or immediately after pregnancy

Malaria and sickle cell disease are additional risk factors

Clinical suspicion of thrombo-embolism should be investigated further and treated with a safe anticoagulant regimen during pregnancy and for at least 6 weeks postpartum

Subcutaneous heparin injection is the mainstay of treatment antenatally, whilst warfarin may be used postpartum

Delivery should be planned in advance when a woman is receiving anticoagulant treatment as she is at significant risk of bleeding

Regional anaesthetic techniques are contra-indicated if the clotting screen is abnormal

Thrombo-prophylaxis should be given to all mothers following caesarean section according to body weight

Amniotic fluid embolism and massive air embolism are rare complications of delivery.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.